Allarity Therapeutics (ALLR) vs Dare Bioscience (DARE)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Allarity Therapeutics (ALLR) has outperformed Dare Bioscience (DARE) over the past year, losing 42.2% versus a loss of 64.8%. Allarity Therapeutics is the larger company by market cap ($15.6 million vs $15.2 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ALLR | DARE |
|---|---|---|
| Share price | $0.9819 | $0.7722 |
| Market cap | $15.62M | $15.19M |
| 1-day change | -0.21% | -2.25% |
| YTD return | -9.08% | -59.07% |
| 1-year return | -42.24% | -64.81% |
| 5-year return | — | -95.81% |
| EPS (TTM) | $-0.79 | $-0.71 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.84 | $3.78 |
| 52-week low | $0.769 | $0.69 |
| Distance from 52-week high | -46.64% | -79.57% |
| Analyst consensus | none | none |
| Avg. price target upside | +1020.28% | +978.74% |
| Average volume | 90.63K | 524.37K |
| Shares outstanding | 15.91M | 19.67M |
| Employees | 7 | 21 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ALLR has outperformed DARE by 22.6 percentage points over the past year.
About Allarity Therapeutics
ALLR stock →Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing anti-cancer therapeutics for patients with unmet medical needs in Denmark and the United States. The company develops drugs for the personalized treatment of cancer using drug-specific companion diagnostics generated by its proprietary drug response predictor (DRP) technology.
Healthcare · Biotechnology · 7 employees
About Dare Bioscience
DARE stock →Daré Bioscience, Inc. develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States.
Healthcare · Biotechnology · 21 employees
ALLR vs DARE FAQ
Which is bigger, Allarity Therapeutics or Dare Bioscience?
Allarity Therapeutics (ALLR) is larger, with a market capitalization of $15.62M compared with $15.19M for Dare Bioscience (DARE).
Which stock has performed better over the past year, ALLR or DARE?
ALLR returned -42.24% over the past 12 months, compared with -64.81% for DARE (price return, excluding dividends). Past performance does not predict future results.
Are Allarity Therapeutics and Dare Bioscience in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.